INTRODUCTION {#SEC1}
============

Post-transcriptional gene regulation mediated by RNA-binding proteins (RBPs) is a versatile mechanism that modulates the localization, stability and translation of many protein coding genes ([@B1]). Originally identified in *Drosophila* for controlling sensory organ development ([@B2]), the Musashi (Msi) RBPs are now implicated to have important functions in the neural, hematopoietic and gastrointestinal systems in many species including worm, fly, mouse and human ([@B3]--[@B8]). In vertebrates, the *Msi* family consists of the paralogs, *Msi1* and *Msi2*, which share a high degree of similarity in their RNA binding domains (RBDs) but also show divergence in their carboxyl terminal (C-terminal) domains ([@B9]). Loss of *Msi2* in hematopoietic or gastrointestinal systems results in stem cell depletion and compromises normal tissue functions ([@B5],[@B8]). Conversely, overexpression of *Msi2* drives pathologic cellular proliferation in these systems and is associated with poor prognosis in patients with malignant leukemia ([@B3],[@B5]).

To elucidate the molecular underpinning responsible for the oncogenic activities of *Msi2*, recent works have begun to utilize genomic tools to identify *Msi2* targets globally and characterize the regulatory network governed by *Msi2* ([@B6],[@B8]). Transcriptome-wide binding assays, such as HIgh-Throughput Sequencing of RNA isolated by CrossLinking ImmunoPrecipitation (HITS-CLIP), were used to identify a number of *Msi2* targets involved in cell cycle control in human leukemia cell lines and murine intestinal progenitor cells. Although these studies attempted to identify *Msi2* targeted mRNAs *in vivo*, the primary sequence motif recognized by Msi2 is unclear as numerous divergent sequence motifs were identified ([@B8]). In contrast, biochemical and structural analysis of Msi binding sites in experimentally identified targets, *Numb* and *Jag1*, and *in vitro* target selection experiments have identified a tripartite nucleotide sequence, UAG, as the prominent recognition motif for both *Msi1* and *Msi2* ([@B4],[@B9],[@B10]). Thus, the discrepancy between HITS-CLIP identified *in vivo* targets and biochemically examined *in vitro* binding sites highlights the importance of further investigation into Msi2-recognized targets *in vivo* and warrants experimental identification of *Msi2* targets in a cell context-specific manner.

The Msi proteins are suggested to regulate translation of their targeted mRNAs primarily based on studies of *Msi1*. A region in the C-terminal of Msi1 interacts with poly(A) binding protein (PABP) and competes with eIF4G for the interaction, which results in inhibition of translation ([@B11]). Consistent with this result, a recent study using RNA-seq and ribosome profiling (Ribo-seq) showed that the overexpression of *Msi1* inhibits translational efficiency (TE) without causing significant changes to mRNA levels in cultured neural stem cells isolated from mouse embryos ([@B4]). However, due to the lack of confidently identified *Msi2* targets and the apparent differences in the C-terminal sequences between Msi1 and Msi2, it remains unclear if this mode of gene silencing is also the predominant mechanism for *Msi2*. Additionally, since *Msi2* is broadly expressed in many tissue types including epithelial and neural tissues, this suggests that *Msi2* may regulate additional processes distinct from cell growth and stem cell dynamics.

In this study, we identify novel targets and cellular processes regulated by Msi2 by mapping the transcriptome-wide RNA targets and binding sites in primary mouse keratinocytes. Using HITS-CLIP to capture Msi2 associated RNAs in intact cells, we show that the *in vivo* binding motifs of Msi2 are highly enriched for both single and clustered, multiple copies of UAG in the 3′UTR of mRNAs. RNA-seq and Ribo-seq analyses demonstrate that *Msi2* primarily promotes mRNA decay without significantly altering TE. Importantly, we detect novel *Msi2* targets that are involved in regulation of focal adhesion (FA), extracellular matrix (ECM)-receptor interaction and the actin cytoskeleton, in addition to regulators of cell proliferation and survival. Guided by these findings, we show that the loss of *Msi2* increases the migration of keratinocytes, at least in part, by regulating FA while reducing proliferation by inhibiting cell cycle progression and inducing apoptosis. In support of these results, in wounded skin *Msi2* is strongly downregulated in the epidermal stem/progenitor cells, located at the leading edge of the wound. These findings provide new insights into the molecular mechanisms of *Msi2*-mediated gene repression in mammalian cells and define *Msi2* as a novel regulator of epithelial migration and growth.

MATERIALS AND METHODS {#SEC2}
=====================

RNA-stability measurements {#SEC2-1}
--------------------------

Approximately 300 000 shRNA producing keratinocytes were plated into five 6 cm dishes and allowed to grow in E-Low Media as previously described ([@B13]). Once cells reached ∼80% confluency media was supplemented with 5 ug/ml Actinomycin D (Thermo Fisher). The zero time point was marked starting 5 min after Actinomycin D addition. Cellular RNA was harvested using Trizol (Thermo Fisher) at time 0, 2, 4, 6 and 8 h and used in qPCR for targets (Supplementary Table S2 for qPCR primer sequences). Relative expression was computed and normalized to the 0 h time point for each target from four technical replicates using ΔΔCq method normalized to *Hprt* and *Gapdh* values with error bars denoting standard error of the mean. RNA half-lives were calculated from linear regression of log transformed expression values for each target as described previously ([@B12]). ANCOVA analysis was performed on the resulting regression lines to assess statistical significance.

Msi2 HITS-CLIP {#SEC2-2}
--------------

Msi2 HITS-CLIP was performed as previously described for Ago2-HITS-CLIP with minor modifications ([@B13]). Briefly, 15 cm dishes of mouse keratinocytes were irradiated with 200 mJ/cm with 254 nm UVC light, harvested by scraping and stored at −80°C. After lysis, the lysates were then treated with 10 μl per ml lysate Turbo DNase (Thermo Fisher), 5 μl per ml lysate RNase OUT (Thermo Fisher), and partially digested with 10 μl of either a 1:1, 1:20, 1:50 or a 1:75 dilutions of an RnaseA/T1 mix (Sigma/Ambion 1x mix = 3.33 μl Rnase-A (2 μg/μl) with 6.66 μl Rnase-T1 (1 U/μl). Crosslinked Msi2 was immunoprecipitated for 2 h at 4°C using 5μg of an anti-Msi2 antibody (Supplementary Table S2) complexed with Protein-G Dynabeads (Thermo Fisher). After end-labelling, 5′adaptor ligation, and phosphatase treatment Msi2-RNA complexes were resolved on a 10% Novex Bis-Tris gel (Thermo Fisher) and transferred to a nitrocellulose membrane (GE Healthcare Life Sciences). The nitrocellulouse was subsequently exposed to X-ray film and a phosphor screen overnight. Protein--RNA complexes migrating between 40 and 60 kDa for the 1:1 and 1:20 RNase dilutions or 70--160+ kDa for the 1:20, 1:50 and 1:75 RNase dilutions were isolated from the nitrocellulose. RNA was extracted by Proteinase-K treatment followed by acidic Phenol-Chloroform extraction and ethanol precipitation. After ligation and reverse transcription, the cDNA were subject to 20 cycles of PCR, purified on a 10% native PAGE gel and subject to 1 × 100 sequencing on an Illumina HiSeq 2000.

Ribosome profiling and RNA-seq library preparation {#SEC2-3}
--------------------------------------------------

Ribosome profiling was performed on scrambled shRNA and *Msi2* knockdown keratinocytes using the ART-Seq Ribosome profiling kit (Illumina). Briefly, cultured cells were grown to ∼80% confluency on a 15 cm plate and treated with 50 ug/ml cyclohexamaide for 1 min before they were lysed, aliquoted and digested with RNase. Ribosomes and associated RNA were isolated using illustra™ MicroSpin™ S-400 HR Columns (Illumina). RNA was extracted from the isolate and rRNA was depleted once using Ribo-Zero Gold™ kit (Illumina). RNA fragments 28--32 nts long were isolated via denaturing PAGE gel, ligated to a 3′ adapter, reverse transcribed, circularized using CircLigase, depleted for rRNA a second time and PCR amplified following the provided protocol. RNA-seq was performed using the NEBNext Ultra Directional RNA Library Prep Kit for Illumina (New England BioLabs) with minor modifications using lysate matched to the ribosome profiling samples. Briefly, mRNA was isolated from total RNA using Dynabeads mRNA DIRECT Micro Purification Kit (Thermo Fisher) and fragmented for 15 min at 94°C. First strand synthesis, second strand synthesis, end repair, adapter ligation and PCR were performed as described in provided protocol. All PCR products were sequenced on an Illumina HiSeq 2000 using 1 × 100 sequencing.

RESULTS {#SEC3}
=======

Msi2-HITS-CLIP identifies Msi2 associated RNA targets {#SEC3-1}
-----------------------------------------------------

*Msi2* is highly expressed in skin progenitor and stem cells of both interfollicular and hair follicle lineages in intact mouse skin and in cultured keratinocytes (Supplementary Figure S1). In addition, using previously published RNA-seq data from total epidermis ([@B14]), we found that *Msi2* is more than 9-fold more abundant than *Msi1*, a paralog of *Msi2*, suggesting that *Msi2* is the dominant Msi protein in the epidermis (Supplementary Figure S1F). Furthermore, the same dominant expression of *Msi2* over *Msi1* was also detected in RNA-seq and ribosome profiling (Ribo-seq) data from keratinocytes (see below), in which *Msi2* is ∼13-fold more abundant than *Msi1* (Supplementary Figure S1F). Lastly, in our previous study, we generated genome-wide proteomics data from neonatal murine epidermis ([@B15]). These mass spectrometry data demonstrated that Msi2 protein is detectable, whereas Msi1 is at undetectable levels (Supplementary Figure S1F). Altogether, these data document that *Msi2* is the dominant Msi protein expressed in the epidermis.

To understand how Msi2 recognizes its targets in intact cells, we first identified *Msi2* target mRNAs by performing Msi2-HITS-CLIP on mouse keratinocytes (Supplementary Figure S2A). RNA fragments crosslinked to Msi2 by UV radiation were isolated from lysates treated with different concentrations of RNase A/T1. High RNase treatment resulted in a relatively uniform band with an apparent molecular weight of ∼40 kD, slightly larger than the anticipated 37 kD of Msi2, and low RNase treatment resulted in a broad smear between ∼60 and 110 kD, confirming capture of an RNase-sensitive Msi2-RNA complex (Figure [1A](#F1){ref-type="fig"}). Of note, partial RNase digestion and recovery of the longer RNA fragments protected by Msi2 would enhance our ability to identify Msi2 binding sites ([@B16]). We sequenced five libraries with varying sized Msi2-associated RNA fragments (Supplementary Figure S2B and C). Thirty-four million reads were recovered with ∼350 000 unique reads that were unambiguously mapped to the mouse genome. Overall, the largest portion of the mapped reads aligned to 3′UTRs (36.47%), followed by intronic regions, noncoding RNAs, intergenic regions and coding regions (CDS) (Figure [1B](#F1){ref-type="fig"}). Overlapping reads were merged together to generate Msi2 binding peaks. We then defined a set of high confidence peaks by requiring at least four out of five libraries to have at least one read per peak and the peak to contain a minimum of 10 total reads. Peaks located in 3′UTRs (65.93%) stood out again as the most dominant region after peak filtering whereas peaks covering intronic and intergenic regions were reduced to 8.86% and 1.88% respectively after filtering, suggesting that intronic and intergeneic binding events may be the result of spurious binding or alignment artifacts (Figure [1B](#F1){ref-type="fig"}). Overall, 75.66% of the Msi2-HITS-CLIP peaks were located in mRNAs, with 87.14% of those peaks located in the 3′UTR. Metagene plots demonstrated that the read and peak distribution across mRNA transcripts were strongly enriched in the 3′UTR region (Figure [1C](#F1){ref-type="fig"}). Within the 3′UTR, neither the reads distribution nor peak distribution showed a strong preference towards either the stop codon or the 3′ terminus of the transcript (Figure [1C](#F1){ref-type="fig"}). These data provide a genome-wide view of Msi2\'s strong preference to 3′UTR of mRNAs.

![Msi2-HITS-CLIP identifies direct *Msi2* targets in keratinocytes. (**A**) Autoradiogram of ^32^P-labelled Msi2-RNA complexes treated with different RNase concentration resolved on a 10% Bis-Tris gel. (**B**) Pie chart of the genomic locations of the aligned reads and filtered peaks before (left panel) and after (right panel) the filtering processes, respectively. (**C**) Metagene of exonic coverage along a scaled mRNA for aligned reads (top panel) and filtered peaks (bottom panel). Reads densities are normalized for library sizes. Peak and reads densities are averaged along all detectable transcripts based on RNA-seq (see 'Materials and Methods'). (**D**) Msi2 recognized motifs are identified from *de novo* motif search for 3--9 mers in the 3′UTR peaks. The top motif identified for each N-mer search is displayed and positioned to highlight the shared UAG motif. (**E**) Motif occurrences are tabulated in a +/- 100-nucleotide window surrounding the peak summits for all 3--9mer motifs displayed in panel D (top panel) or UAG (bottom panel). (**F**) Number of UAG motif ([@B1]--[@B4]) occurrences in a +/- 225-nucleotide window around the peak summit in CLIP sites, flanking region or random 3′UTR background (left panel), with Fisher Exact Test showing motif enrichment in CLIP sites over the flanking region or 3′UTR background (right panel). (**G**) Gene tracks of Msi2 HITS-CLIP reads for Msi2 bound transcripts. Reads from all libraries were combined and positive strand reads are coloured blue whereas the negative strand reads are coloured green. The UAG motifs and its reverse complement, CUA, in a window around the peak summits are highlighted in red.](gkw207fig1){#F1}

To probe Msi2 recognized binding sites *in vivo*, we performed *de novo* motif searching to detect sequence-specific signatures of Msi2 binding within 3′UTR, 5′UTR, intronic and CDS regions. We found enrichment for a set of motifs in the 3′UTRs that contained a 3-nucleotide UAG core element (Figure [1D](#F1){ref-type="fig"}), supporting previous *in vitro* results obtained from SELEX as well as structural and biochemical studies ([@B9],[@B10],[@B17]). In addition, only peaks located in 3′UTRs generated a confidently enriched and coherent set of motifs, indicating that Msi2 primarily binds the 3′UTR of mRNA transcripts by recognizing UAG containing motifs (Figure [1D](#F1){ref-type="fig"}, Supplementary Figure S3A--C).

The relative position of the UAG core motif or all identified 3--9mer motifs in aggregate showed a significant enrichment around the summit of the HITS-CLIP peaks, defined as the middle of the region in a peak with the greatest read coverage over the background, further supporting that our HITS-CLIP approach detected mRNA regions directly recognized and protected by Msi2 (Figure [1E](#F1){ref-type="fig"}, Supplementary Figure S4A). Because both Msi2 and Msi1 contain two RNA recognition motifs (RRMs) and each is believed to interact with a UAG motif ([@B9]) and because the 7--9mer motifs identified consisted of repeated adjacent UAG sequences, we wanted to determine if the RNA regions recognized by Msi2 were enriched for multiple UAGs. We observed a significant enrichment of two or more UAG motifs within a 50 nt window surrounding the peak summit of the Msi2 binding sites, in contrast to randomized 3′UTR regions or regions flanking the binding sites (Figure [1F](#F1){ref-type="fig"}). This suggests that multiple UAGs may be required for Msi2 recognition. These multiple clustered UAG motifs within a short distance probably provide a mechanism for Msi2 to distinguish *bona fide* binding sites from random UAG sequences that are prevalent in the genome. Indeed, inspection of a representative set of targets demonstrated widespread existence of the UAG motif in the 3′UTRs and multiple UAGs were enriched within a portion of the HITS-CLIP identified Msi2 binding regions (Figure [1G](#F1){ref-type="fig"} and Supplementary Figure S5). However, it was clear, based on the widespread distribution of UAGs within these individual examples, that UAG alone is not sufficient for predicting Msi2 binding due to the large number of non-clipped UAGs. Furthermore, the lack of UAG was also observed in some peaks, indicating that additional elements or features may be used for Msi2 recognition (Supplementary Figure S5).

In addition, because the RRMs are highly similar between Msi1 and Msi2 ([@B9]), we also assessed the positional distribution of the Msi1 consensus motif, (G/A)U(*n*)AGU (*n* = 1--3), previously identified by SELEX ([@B17]). Notably, the GUAGU motif showed more robust enrichment near the peak summit than the GUUAGU motif did whereas the GUUUAGU or AU~1-3~AGU motifs were not enriched (Supplementary Figure S4B). These data suggest that GU~1-2~AGU motifs may also be bound by Msi2 *in vivo*. Altogether, our Msi2-HITS-CLIP reveals characteristics of Msi2 binding and identifies a trinucleotide UAG core Msi2 recognition motif in intact cells.

Loss of *Msi2* increases targeted mRNA abundance {#SEC3-2}
------------------------------------------------

One thousand one hundred and ninety-nine mRNAs were identified as Msi2 recognized targets with at least one Msi2 HITS-CLIP peak located in the 3′UTR. To determine molecular effects of Msi2 binding to these targeted transcripts, we knocked down *Msi2* in cultured mouse keratinocytes using two short hairpin RNAs (shRNA) and measured steady-state mRNA abundance and ribosome associated mRNAs by RNA-seq and ribosome profiling (Ribo-seq) ([@B18]), respectively (Figure [2A](#F2){ref-type="fig"}). Knockdown of *Msi2* using both shRNAs, one targeting the 3′ UTR and the other targeting the coding regions, achieved highly efficient reduction of protein levels (Figure [2B](#F2){ref-type="fig"}). All subsequent experiments utilized the 3′UTR targeting shRNA (shMsi2). Additionally, the Ribo-seq data showed the expected phasing of reads in the CDS, consistent with capturing actively translating messages (Supplementary Figure S6).

![Loss of *Msi2* increases targeted mRNA abundance without affecting TE. (**A**) Flow-chart of experimental design. (**B**) Western blot against Msi2 on keratinocytes infected with indicated shRNA lentiviral construct. (**C, F**) Log2 fold change plotted against Log2 mean expression for RNA-seq (C) and Ribo-seq (F) libraries. Significantly changed genes with FDR \< 0.05 plotted in red. (**D, G**) Cumulative distributions of changes in mRNA abundance (RNA-seq) (D) and ribosome occupancy (Ribo-seq) (G) after *Msi2* knockdown. Genes with 3′UTR Msi2-HITS-CLIP peaks are plotted in red, genes without 3′UTR Msi2-HITS-CLIP peaks are plotted in blue. The number of genes in each category is indicated in parenthesis. (**E, H**) Cumulative distributions as in panels D and G, with genes with one, two or three or more 3′UTR Msi2-HITS-CLIP peaks plotted separately. (**I**) Comparison of log~2~ fold-changes for RNA-seq and Ribo-seq. Pearson correlation coefficient displayed. (**J**) Cumulative distributions of changes in translation efficiency for genes containing or not containing 3′UTR Msi2-HITS-CLIP peaks. (Kolmogorov-Smirnov Test one-sided). (**K**) Mean log~2~ fold-changes for RNA-seq, Ribo-seq and translation efficiency for genes containing or not containing 3′UTR Msi2-HITS-CLIP peaks. Standard error of the mean is displayed.](gkw207fig2){#F2}

RNA-seq detected 3856 dysregulated genes whereas Ribo-seq detected 486 differentially expressed genes in the *Msi2* knockdown cells (FDR \<0.05) (Figure [2C](#F2){ref-type="fig"} and [F](#F2){ref-type="fig"}). The differences were likely due to lower sequencing coverage in the Ribo-seq dataset. Of the 1199 target mRNAs identified through HITS-CLIP, 1117 were detectable by both RNA-seq and Ribo-seq after filtering out genes with low coverage (minimum baseMean of 10 in shScr libraries). A cumulative distribution function was then used to compare the RNA-seq and Ribo-seq fold change of the 1117 targeted mRNAs versus the non-targeted mRNAs to assess *Msi2*\'s effects in target mRNA levels and ribosome occupancy. Msi2 bound mRNAs were more likely to be upregulated and additionally have more ribosome occupancy upon reduction of *Msi2* levels (Figure [2D](#F2){ref-type="fig"} and [G](#F2){ref-type="fig"}). Furthermore, the trend toward increased mRNA and ribosome occupancy for *Msi2* targets was positively correlated with increasing number of detected Msi2 binding sites, reflecting a dosage response of *Msi2* targets to Msi2 binding (Figure [2E](#F2){ref-type="fig"} and [H](#F2){ref-type="fig"}). These data are consistent with *Msi2* acting as a repressive regulatory RBP.

A recent study suggested that *Msi2* functions to regulate TE of individual targets when overexpressed ([@B4]). However, our global measurements with *Msi2* knockdown suggested that the change in ribosome occupancy and mRNA abundance for *Msi2* targets was highly correlated (Figure [2I](#F2){ref-type="fig"}). These results raised a possibility that *Msi2* regulates target mRNA stability in addition to modulating ribosome occupancy. To investigate this mechanism, we examined the impact that loss of *Msi2* had on TE by calculating the ratio of normalized ribosome protected fragments to normalized RNA-seq reads per transcript. Overall, the TE was unchanged for *Msi2* targets upon reduction of *Msi2* (Figure [2J](#F2){ref-type="fig"} and Supplementary Figure S7A), as illustrated by the cumulative distribution of TE changes, or by comparing the mean fold RNA-seq, Ribo-seq or TE change of *Msi2* targets versus non-targets (Figure [2K](#F2){ref-type="fig"}). This effect was also evident for individual genes when we analyzed the previously identified *Msi2* target *Jag1* and found mRNA and ribosome occupancy were both significantly increased upon *Msi2* knockdown (Supplementary Figure S7B and C).

In addition to binding to 3′UTR regions, Msi2 binding was also detected in 5′UTR, coding and intronic regions at a much lower frequency (Figure [1B](#F1){ref-type="fig"}). The number of genes containing 5′UTR, CDS or intron binding events were very low (8, 44 and 33 genes respectively), compared to the 3′UTR binding events. However, in addition to 3′UTRs, genes with Msi2 CDS binding events were more likely to be upregulated when *Msi2* was depleted, in contrast to 5′UTR and intron binding events, which did not demonstrate any discernible trend (Supplementary Figure S8A--C). Taken as a whole, these data support the notion that *Msi2* promotes targeted mRNA decay primarily through association with the 3′UTR and, to a lesser extent, the CDS, similar to what has been reported for miRNAs, another class of post-transcriptional regulators ([@B19],[@B20]).

*Msi2* regulates target mRNA stability {#SEC3-3}
--------------------------------------

To independently validate that *Msi2* regulates RNA stability, we selected a subset of targets and assayed their steady-state transcript levels by qPCR and the rate of mRNA decay upon Actinomycin D treatment. Eight genes (*Itga2, Thbs1, Hbegf, Cxcl5, Sema3c, Igfbp3, Ppbp and Itgb1)* that exhibited mRNA abundance increases and increased ribosome occupancy in the absence of *Msi2* were selected for validation in addition to a nontargeted and unchanged gene, *Src*, for comparison (Supplementary Figure S7D). The steady-state mRNA levels of all eight selected *Msi2* targets were found to be upregulated in independently generated *Msi2* knockdown cell lines while *Src* was not significantly changed (Figure [3A](#F3){ref-type="fig"}). Additionally, we performed Msi2 immunoprecipitation followed by qPCR and found that the eight targets were enriched in Msi2 immunoprecipitates over control genes *Gapdh* and *Hprt*, confirming their association with Msi2 proteins, while *Src* showed no enrichment (Figure [3B](#F3){ref-type="fig"}). To determine the stability of the target mRNAs, RNA decay curves for the eight targets and *Src* were assayed using an Actinomycin D time course in *shScr* and *shMsi2* keratinocytes followed by qPCR. Unfortunately, *Itga2* was too lowly expressed in shScr to accurately assess RNA stability. Additionally, *Ppbp* suffered from poor qPCR detection and normalization and was excluded from the analysis. Nevertheless, all other target mRNAs except *Thbs1* were significantly more stable in the absence of *Msi2* (Figure [3C](#F3){ref-type="fig"}). While *Thbs1* changes did not achieve statistical significance, it also trended toward being more stable in *Msi2* knockdown samples. In support of this observation, RNA half-lives were calculated from the decay curves and found to be anywhere from 2--7-fold higher in *Msi2* knockdown cells over the scrambled control counterparts (Figure [3D](#F3){ref-type="fig"}). These data demonstrate that *Msi2* likely functions to repress target genes at least in part by de-stabilizing the mRNA transcript.

![*Msi2* functions by promoting target mRNA decay. (**A**) qPCR detection of the expression of selected *Msi2* targets in scrambled control and *Msi2* knockdown keratinocytes. (*n* = 4 biological replicates, \*\**P* \< 0.01; \**P* \< 0.05). (**B**) RNA-immunoprecipitation of Msi2 complexes with Msi2 or control rabbit IgG antibody, followed by qPCR detection of the selected *Msi2* targets using *Gapdh* and *Hprt* as non-targeting controls. Relative enrichment was calculated by enrichment over IgG control. Western blot validation of successful Msi2 immunoprecipitation is shown. (\*\**P* \< 0.01; \**P* \< 0.05). (**C**) RNA stability curves plotted using qPCR expression versus time. ANCOVA analysis was used in determining statistical significance. Standard error mean is displayed for each time point. (\*\**P* \< 0.01; \**P* \< 0.05). (**D**) RNA half-lives in hours calculated from the stability curves. ANCOVA *P*-values displayed. \*\**P* \< 0.01; \**P* \< 0.05) (ANCOVA). N.S. not significant.](gkw207fig3){#F3}

*Msi2* targets are highly enriched for genes involved in migration and proliferation {#SEC3-4}
------------------------------------------------------------------------------------

Our identification of direct *Msi2* targets through HITS-CLIP combined with transcriptome and ribosome occupancy measurements provided a platform to identify molecular pathways regulated by *Msi2*. A list of regulated *Msi2* targets with Msi2 binding sites was generated as follows: genes were filtered for FDR \< 0.05 in both Ribo-seq and RNA-seq as calculated by DEseq and cross-referenced with the high-confidence 3′UTR HITS-CLIP peaks (Figure [4A](#F4){ref-type="fig"}). Putative targets in this list were largely upregulated in the absence of *Msi2* (88 out of 119, 74%), consistent with *Msi2* being a negative regulator of gene expression (Figure [4B](#F4){ref-type="fig"}). We deemed these 88 genes exhibiting upregulation in both RNA-seq and Ribo-seq upon *Msi2* knockdown as high confidence *Msi2* targets (Supplementary Table S1).

![*Msi2* targets are highly enriched for regulators of migration and proliferation. (**A**) Schematic depicting analysis method to extract high-confidence *Msi2* targets. (**B**) Proportion of genes upregulated in combined RNA-seq/Ribo-seq background data, or the identified high-confidence putative *Msi2* targets. *P* value was assessed with Chi-Squared test. (**C**) Ingenuity Pathway Analysis of genesets derived from panel A. The top terms for molecular and cellular functions are displayed. Note that only genes upregulated upon loss of *Msi2* were selected for analysis. (**D**) Ingenuity Pathway analysis of 88 high confidence *Msi2* targets. (**E**) KEGG Pathway enrichment of 88 high confidence *Msi2* targets.](gkw207fig4){#F4}

In order to identify a common group of pathways that are regulated by Msi2, each parental dataset (HITS-CLIP, RNA-seq and Ribo-seq) was analyzed using Ingenuity Pathway Analysis (IPA). Genes involved in cell proliferation, survival and cell cycle were among the top pathways enriched in all datasets, consistent with previously reported functions of *Msi2* in promoting cell growth ([@B3]--[@B5],[@B8]) (Figure [4C](#F4){ref-type="fig"}). Surprisingly, a significant enrichment for targets involved in cell movement was also commonly detected in all datasets, indicating a widespread effect of *Msi2* on cell migration (Figure [4C](#F4){ref-type="fig"}). Importantly, when the high confidence targets were analyzed with IPA, cellular movement was identified as the most enriched pathway, followed by proliferation and survival (Figure [4D](#F4){ref-type="fig"}). In particular, KEGG pathway analysis highlighted genes involved in FA, ECM-receptor interaction and the actin cytoskeleton (Figure [4E](#F4){ref-type="fig"}). These data suggest a possibility that *Msi2* controls cellular movement by regulating expression levels of regulators in these pathways.

Within the list of *Msi2* targets are many genes that have functions in cell migration, including *Flnb/a, Plec, Lama3*, and many of the targets selected for qPCR validation and RNA-stability measurements, *Itgb1, Itga2, Hbegf, Cxcl5, Sema3c, Igfbp3* and *Ppbp* (Supplementary Table S1). Furthermore, consistent with *Msi*\'s known functions in regulating the Notch signaling pathway ([@B17],[@B21]), *Dll1, Jag1* and *Notch2* are found among the high-confidence *Msi2* targets, providing additional evidence for *Msi2*\'s role in the Notch pathway (Figure [4E](#F4){ref-type="fig"}, Supplementary Table S1).

We next compared the HITS-CLIP identified targets in our study to previously published results for *Msi2* in the blood and intestine (Supplementary Figure S9A). A number of common targets (221) were identified in addition to a large number of mRNAs unique to each experiment. Interestingly, when GO term analysis was performed for the common and cell type-specific targets, we found GO terms related to cell migration were most prominently enriched in our dataset (Supplementary Figure S9B and C), while the commonly identified 221 genes were not strongly enriched for any GO term related to cell migration (Supplementary Figure S9D). These results demonstrate that *Msi2* regulates both common and distinct mRNA targets in different cell-types, and additionally suggests that *Msi2* may regulate cellular pathways in a cell-type specific manner.

*Msi2* promotes cell proliferation and survival in keratinocytes {#SEC3-5}
----------------------------------------------------------------

*Msi2* has previously been shown to play a critical role in regulating cellular proliferation in many systems ([@B3],[@B4],[@B8]). Interestingly, in our high confidence targets we detected negative regulators of cell-cycle progression and pro-apoptotic factors including the DNA damage checkpoint regulator *Atm*, and the pro-apoptotic inducer *Pmaip1*. We thus assessed the role of *Msi2* in regulating keratinocyte proliferation and survival. Keratinocytes with reduced *Msi2* demonstrated reduced colony forming ability in contrast to *Msi2* overexpression, which resulted in enhanced colony forming ability (Figure [5A](#F5){ref-type="fig"}). Additionally, introduction of an shRNA resistant *Msi2* cDNA into the knockdown cells rescued the impaired colony forming phenotype (Figure [5A](#F5){ref-type="fig"} and [B](#F5){ref-type="fig"}). To further characterize this phenotype, the doubling times of *shScr, shMsi2*, overexpression and rescued keratinocytes were examined. Loss of *Msi2* reduced the doubling time by ∼50%. Whereas, overexpression of *Msi2* increased doubling time by ∼15% (Figure [5C](#F5){ref-type="fig"}). The rescue of *Msi2* expression in *shMsi2* cell lines returned the doubling time to near control levels, validating that the cell growth phenotype is a result of loss of *Msi2*.

![*Msi2* promotes keratinocyte proliferation. (**A**) Colony formation assay of keratinocytes with control (*MIGR-Vec/shScrCtrl*), *Msi2* overexpression (*MIGR-Msi2/shScrCtrl*), *Msi2* knockdown (*MIGR-Vec/shMsi2*) or co-infected (*MIGR-Msi2/shMsi2*) to rescue *Msi2* levels in the knockdown condition. Results are representative of two independent biological samples each assayed in triplicate. (**B**) Crystal violet quantification of colony forming and western blot of keratinocytes infected with the indicated lentiviral and retroviral constructs to knockdown or overexpress *Msi2*, respectively. Standard error mean displayed. (**C**) Growth curves of keratinocytes. Results are representative of *n* = 2 independent biological replicated plated in duplicate. (**D**) Cell cycle analysis of EdU pulsed keratinocytes with Ctrl and knockdown of *Msi2*. Representative chart of cell populations shown with quantification of *n* = 5 biological replicates. \**P* \< 0.05. (Student T-Test two-way). N.S.: not significant. (**E**) Propidium iodide and Annexin V flow cytometry analysis performed in triplicate to identify the population of apoptotic cells. Representative result displayed from *n* = 3 independent experiments (Student T-test two-way).](gkw207fig5){#F5}

To explore the mechanism by which *Msi2* promotes cell growth, we performed cell cycle analysis by EdU incorporation. Loss of *Msi2* results in an increased G1 population and reduced S and G2/M populations, suggesting that *Msi2* regulates the G1-S transition (Figure [5D](#F5){ref-type="fig"}). Additionally, the sub-G1 population, reflective of apoptotic or necrotic cells, was significantly increased in the *Msi2* knockdowns, indicating that the observed growth differences are caused by defects in both cell proliferation and survival (Figure [5D](#F5){ref-type="fig"}). To measure apoptosis induced by *Msi2* knockdown, Annexin-V/PI staining was performed. The knockdown cells showed ∼2-fold increased levels of Annexin-V positive apoptotic cells when compared to control scrambled cells (Figure [5E](#F5){ref-type="fig"}). Together, these results provide evidence that *Msi2* regulates cell proliferation by controlling cell cycle progression and survival in keratinocytes.

*Msi2* inhibits keratinocyte migration {#SEC3-6}
--------------------------------------

Unexpectedly, our analyses identified many targets of *Msi2* involved in the regulation of cell migration. Indeed, the mRNA targets selected for qPCR validation are all involved in cell migration, as either structural adhesion molecules or regulators of cell migration processes. Among *Msi2* targets, *Itga2, Itgav* and *Itgb1* are integrin subunits that form heterodimeric transmembrane protein complexes. These proteins mediate cell--cell or cell--ECM attachment and have regulatory effects on cell migration ([@B22]). Similarly, the glycoprotein *Thbs1*, also known as *TSP-1*, mediates cell-to-cell or cell-matrix interactions through binding a multitude of receptors and can act to simulate or inhibit migration depending on the cellular context ([@B23]). *Cxcl5* and *Ppbp* are members of the secreted chemokine CxC ligand family that stimulate cell migration in addition to providing chemoattractant cues ([@B24],[@B25]). Additionally, *Sema3c*, a member of the semaphorin family, stimulates cell migration in diverse tissues ([@B26]). Lastly, *Igfbp3*, an insulin growth factor binding protein, can regulate cell migration in a cellular context dependent manner ([@B27],[@B28]).

To investigate the role of *Msi2* in cell migration, individual cells were tracked using live-cell imaging permitting the measurement of cell migration speed and direction ([@B29]). This approach allowed us to investigate cellular migration differences between control and *Msi2* knockdown cells independent of cell proliferation rates. Consistent with the identification of numerous *Msi2* targets involved in cell migration, loss of *Msi2* significantly perturbed keratinocytes migration. *Msi2* knockdown cells demonstrated enhanced migration speed compared to scrambled control (Figure [6A](#F6){ref-type="fig"} and [B](#F6){ref-type="fig"}). Migratory tracks of individual cells revealed no tendency for changed migratory patterns upon *Msi2* knockdown (Figure [6C](#F6){ref-type="fig"}).

![*Msi2* inhibits keratinocyte migration and is downregulated during skin wound healing. (**A**) Cellular migration speed is measured over time for the control and *Msi2* knockdown keratinocytes. Data shown are representative of two independent experiments. (**B**) Average migration speed for the control and *Msi2* knockdown keratinocytes. (**C**) Example cell migration tracks for the control and *Msi2* knockdown keratinocytes. (**D**) Immunofluorescence of a FA marker, Vinculin (green), and an actin marker, Phalloidin (red), for *shScr* and *shMsi2* keratinocytes. Scale bars = 20 μm. (**E**) Quantification of FA numbers per cell per image for 40 images for *shScr* and *shMsi2* keratinocytes. (**F**) Western blot for Vinculin, beta-Actin and beta-Tubulin in *shScr* and *shMsi2* cell lines. (**G, H**) Immunofluorescence of Msi2 (red) and an epithelial cell marker, E-Cadherin (green) or Msi2 (red) and a basal cell marker, Krt5 (green), in a 7-day old skin wound on mouse backskin. Insertions represent regions at the distal or the leading edge of the wounded site. Asterisks (\*) represent the granulation tissue at the wounded site. Nuclei are shown in blue. Scale bars = 100 μm (inset = 20 μm). \**P* \< 0.05, \*\**P* \< 0.01 (Student two-way T-Test).](gkw207fig6){#F6}

To establish a mechanistic link between *Msi2*-mediated gene expression regulation and cell migration, we turned our focus to the pathways that are most enriched for *Msi2* targeted genes - regulators of FA and the integrin molecules (Figure [4E](#F4){ref-type="fig"}). Extensive studies have linked FA and integrins to cell migration ([@B22],[@B30],[@B31]). However, it is not clear how expression levels of individual components affect FA formation and cell migration. Immunofluorescence and imageJ quantification for Vinculin and Phalloidin to mark FAs and actin, respectively, showed significantly increased numbers of FAs in the *Msi2* knockdown cells without a change in total cellular levels of Vinculin or actin (Figure [6D](#F6){ref-type="fig"}--[F](#F6){ref-type="fig"}). These data suggest that elevated expression and/or utilization of FA components and integrins in the absence of *Msi2* correlates with increased FA formation, likely leading to increased cell migration in these cells.

To further corroborate the role for *Msi2* in inhibiting cell migration in a physiologically relevant condition, we examined *Msi2* expression during wound healing in adult mouse skin. We used Keratin 5 staining to mark the basal layer, which consists of the basal progenitor cells, and E-cadherin to mark all epidermal keratinocytes in order to localize *Msi2*. In both the basal epidermal progenitors and the hair follicle stem cells in intact skin regions, *Msi2* was readily detectable (Figure [6G](#F6){ref-type="fig"} and [H](#F6){ref-type="fig"}). Strikingly, within the epidermis at the leading edge of the wound adjacent to the granulation tissue (marked with an asterisks), *Msi2* was nearly undetectable, yet its expression recovered gradually with increasing distance away from the wound site (Figure [6G](#F6){ref-type="fig"} and [H](#F6){ref-type="fig"}). This observation suggests an intriguing possibility that the downregulation of *Msi2* is a prerequisite step to promote cell migration in keratinocytes at the leading edge of the wound and that precise control of *Msi2* abundance may be required for proper wound healing processes.

DISCUSSION {#SEC4}
==========

In this study, we provide a critical link between the UAG motif that has been determined biochemically *in vitro* and the Msi2: mRNA binding events occurring *in vivo*. We identified *Msi2* targeted mRNAs using an HITS-CLIP approach, which directly crosslinks Msi2 and its associated RNAs and allows transcriptome-wide identification of both Msi2 bound mRNAs and the specific Msi2 binding site. Consistent with the role of *Msi2* as a post-transcriptional regulator, we found that the main regions recognized by Msi2 are 3′UTRs (66%) (Figure [1B](#F1){ref-type="fig"} and [C](#F1){ref-type="fig"}). We also identified a core UAG motif as the critical element for Msi2 recognition, consistent with the previously identified Msi1 motif using biochemical and structural studies (Figure [1D](#F1){ref-type="fig"}). This is in line with the observation that the RBDs of *Msi1* and *Msi2* are highly conserved. However, we found that two or more closely positioned UAG motifs are most significantly enriched within the Msi2 HITS-CLIP peaks instead of a single UAG (Figure [1F](#F1){ref-type="fig"} and [G](#F1){ref-type="fig"}). It also suggests that the two RRMs of Msi2 may each bind to a UAG motif within a short distance for target recognition, providing a mechanism for Msi2 to distinguish its *bona fide* targets among all UAG sequences that are pervasive in the genome. Such a mechanism was also reported for *hnRNPA1, sex-lethal* and other RBPs. Indeed, *Msi1\'s* RRMs, and by extrapolation, *Msi2\'s* RRMs can bind UAG sequences independently, with the linker between the RRMs providing structural guidance and allowing UAGs of varying distance apart to be recognized ([@B9]).

We present several lines of evidence that *Msi2* in keratinocytes primarily controls abundance of targeted mRNAs, likely by promoting mRNA decay, without affecting TE. To determine the molecular consequences of Msi2 binding to their targets, we depleted *Msi2* and measured mRNA abundance and ribosome occupancy by RNA-seq and Ribo-seq, respectively. Recent studies show that *Msi1* functions by regulating translation rather than steady-state RNA levels through the interaction with PABP and competing with eIF4G ([@B4],[@B11]). However, in our study of *Msi2* in keratinocytes, we found that the changes in RNA abundance for *Msi2* targets are very similar to and largely explain the changes in ribosome occupancy (Figure [2](#F2){ref-type="fig"}). Thus, the effect of *Msi2* mediated post-transcriptional regulation is similar to what is ascribed to miRNAs ([@B32]), another prominent class of post-transcriptional regulators, which regulate mRNAs through interaction with DDX6 and the CCR4-NOT complex ([@B20]). We note that *Msi2* differs considerably from *Msi1* in the C-terminal domain, which is likely responsible for recognition and recruitment of downstream effectors for regulating mRNAs. Our finding raises a possibility that *Msi1* and *Msi2* evolve different mechanisms for regulating mRNA abundance and translation. Future investigations that distinguish interacting proteins of Msi1 and Msi2 will be required to delineate precise regulatory mechanisms of *Msi1* and *Msi2*.

Our data reveal a new role of *Msi2* in regulating migration of keratinocytes. Using our HITS-CLIP data together with RNA-seq and Ribo-seq, we generated a list of high-confidence targets that are directly bound and regulated by Msi2 (Figure [4](#F4){ref-type="fig"}). Unexpectedly, we found a large number of regulators of FA, ECM-receptor interaction and the actin cytoskeleton, in addition to cell proliferation and survival, as *Msi2* targets. Interestingly, many of these targets appear to be cell type-specific when we compared our Msi2 results to what were found in blood and intestine (Supplementary Figure S9). Guided by these findings, we demonstrated that the loss of *Msi2* significantly increases cell motility of keratinocytes (Figure [6A](#F6){ref-type="fig"}--[C](#F6){ref-type="fig"}). Furthermore, we documented increased FA numbers in the absence of *Msi2*, likely a molecular underpinning for the enhanced motility. Thus, the collective suppression of FA regulators and integrins by *Msi2* may partly explain the increased cell migration observed in *Msi2* depleted keratinocytes. Altogether, our findings reveal that *Msi2* has dual functions in promoting cell proliferation and inhibiting cell migration in the epidermis.

The role of *Msi2* in migration and its regulation suggest its downregulation could play important roles in normal development and wound healing. *Msi2* appears to be downregulated in the outer root sheath (ORS) progenitors in the normal skin (Supplementary Figure S1B and C). Intriguingly, long-range migration and downwards extension of these ORS progenitors are recently reported to fuel hair follicle growth ([@B33]). We also documented significantly suppressed *Msi2* expression in the leading edge of the wounded skin (Figure [6G](#F6){ref-type="fig"} and [H](#F6){ref-type="fig"}). These data suggest that *Msi2* also regulates migration *in vivo* and *Msi2* downregulation may be an important prerequisite for stimulating cell migration in these cellular contexts.

Additionally, we also identified many targeted signaling pathways in our data sets, including integrin signaling and the Notch signaling pathway (Figure [4E](#F4){ref-type="fig"}, Supplementary Table S1). In our high-confidence *Msi2* targets, we identified five integrin subunits including *Itgb1, Itgb4, Itga2, Itga3* and *Itgav* as well as *Flnb/a, Met* and *Iqgap1*, key regulators of FA and actin dynamics ([@B34],[@B35]). These data provide a molecular basis to investigate *Msi2*\'s role in cell adhesion and motility in epithelial cells. We also identified new components of the Notch signaling pathway including *Notch2* and *Dll1* as *Msi2* targets. This suggests that the regulation of the Notch pathway by *Msi2* is more widespread than currently appreciated. It will also be critical to investigate whether *Msi2*\'s regulation of proliferation and migration is linked through these signaling pathways. Future studies using both gain- and loss-of-function mouse models will begin to answer some of these important questions. In conclusion, our study has provided new insights into *Msi2* target recognition in intact cellular context, molecular mechanisms of target repression and cellular functions in stratified epithelia. These findings provide a foundation to further examine *Msi2* functions in normal development, tissue homeostasis, wound healing and tumorigenesis.
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